The present study demonstrated that FBXO28 expression was associated with poor prognosis in ovarian cancer patients and that the upregulation of FBXO28 was positively correlated with the proliferation, migration and invasion capacity of ovarian cancer cells. Here, FBXO28 is linked to ovarian carcinoma.